Gamida Cell Ltd.

Gamida Cell Ltd.verified

GMDA

Price:

$0.0327

Market Cap:

$4.34M

Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, a natural killer cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. In addition, the company is developing NK cell pipeline comprising GDA-301, GDA-401, GDA-501, and GDA-601 to trea...[Read more]

Industry

Biotechnology

IPO Date

2018-10-26

Stock Exchange

NASDAQ

Ticker

GMDA

The ROE as of December 2024 (TTM) for Gamida Cell Ltd. (GMDA) is 187.96%

According to Gamida Cell Ltd.’s latest financial reports and current stock price. The company's current ROE is 187.96%. This represents a change of -1026.49% compared to the average of -20.29% of the last 4 quarters.

Gamida Cell Ltd. (GMDA) Historical ROE (quarterly & annually)

How has GMDA ROE performed in the past?

The mean historical ROE of Gamida Cell Ltd. over the last ten years is 396.28%. The current 187.96% ROE has changed -52.57% with respect to the historical average. Over the past ten years (40 quarters), GMDA's ROE was at its highest in in the December 2022 quarter at 540.43%. The ROE was at its lowest in in the June 2022 quarter at -466.24%.

Quarterly (TTM)
Annual

Average

396.28%

Median

-90.50%

Minimum

-214.41%

Maximum

2.14%

Gamida Cell Ltd. (GMDA) ROE by Quarter and Year

Discovering the peaks and valleys of Gamida Cell Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 171.67%

Maximum Annual ROE = 2.14%

Minimum Annual Increase = -1014.72%

Minimum Annual ROE = -214.41%

Quarterly (TTM)
Annual
YearROEChange
20232.14%11.02%
20221.92%-1014.72%
2021-210.34%171.67%
2020-77.43%-21.15%
2019-98.19%-54.20%
2018-214.41%158.90%
2017-82.81%-59.95%

Gamida Cell Ltd. (GMDA) Average ROE

How has GMDA ROE performed in the past?

The current ROE of Gamida Cell Ltd. (GMDA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

1.28%

5-year avg

734.86%

10-year avg

396.28%

Gamida Cell Ltd. (GMDA) ROE vs. Peers

How is GMDA’s ROE compared to its peers?

Gamida Cell Ltd.’s ROE is greater than BioLineRx Ltd. (-163.37%), greater than Ardelyx, Inc. (-46.60%), greater than Lexicon Pharmaceuticals, Inc. (-107.38%), less than Seres Therapeutics, Inc. (60.75%), less than ImmunityBio, Inc. (86.39%), less than Protalix BioTherapeutics, Inc. (0%), greater than Iovance Biotherapeutics, Inc. (-30.89%), greater than ImmunoGen, Inc. (-58.43%), less than X4 Pharmaceuticals, Inc. (5.04%), greater than Inozyme Pharma, Inc. (-32.51%), greater than Terns Pharmaceuticals, Inc. (-88.42%), greater than Day One Biopharmaceuticals, Inc. (-32.76%), greater than HOOKIPA Pharma Inc. (-22.40%), greater than null (-49.25%),

Build a custom stock screener for Gamida Cell Ltd. (GMDA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gamida Cell Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gamida Cell Ltd. (GMDA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gamida Cell Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Gamida Cell Ltd.'s ROE?

How is the ROE calculated for Gamida Cell Ltd. (GMDA)?

What is the highest ROE for Gamida Cell Ltd. (GMDA)?

What is the 3-year average ROE for Gamida Cell Ltd. (GMDA)?

What is the 5-year average ROE for Gamida Cell Ltd. (GMDA)?

How does the current ROE for Gamida Cell Ltd. (GMDA) compare to its historical average?